TNF and metabolic dysfunction-associated steatotic liver disease: Network pharmacology studies exploring the mechanism of DCHD in preventing and treating NAFLD have revealed its potential association with the tumor HIF-1 signaling pathway, tumor necrosis factor (TNF) signaling pathway, insulin resistance pathway, among others.